Published in Biochim Biophys Acta on June 15, 2012
In vivo bone regeneration using tubular perfusion system bioreactor cultured nanofibrous scaffolds. Tissue Eng Part A (2013) 1.53
Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties, and applications. Tissue Eng Part B Rev (2013) 1.19
Scaffold design for bone regeneration. J Nanosci Nanotechnol (2014) 1.06
Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications. Mol Ther (2015) 1.02
Biomechanics and mechanobiology in functional tissue engineering. J Biomech (2014) 0.99
Deterministic and stochastic approaches in the clinical application of mesenchymal stromal cells (MSCs). Front Cell Dev Biol (2014) 0.98
Roles of adherent myogenic cells and dynamic culture in engineered muscle function and maintenance of satellite cells. Biomaterials (2014) 0.83
Do hypoxia/normoxia culturing conditions change the neuroregulatory profile of Wharton Jelly mesenchymal stem cell secretome? Stem Cell Res Ther (2015) 0.83
Long term expansion of bone marrow-derived hMSCs on novel synthetic microcarriers in xeno-free, defined conditions. PLoS One (2014) 0.82
Dynamic Bioreactor Culture of High Volume Engineered Bone Tissue. Tissue Eng Part A (2016) 0.82
Enhanced depth-independent chondrocyte proliferation and phenotype maintenance in an ultrasound bioreactor and an assessment of ultrasound dampening in the scaffold. Acta Biomater (2014) 0.79
Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases. Expert Opin Biol Ther (2016) 0.79
A multicompartment holder for spinner flasks improves expansion and osteogenic differentiation of mesenchymal stem cells in three-dimensional scaffolds. Tissue Eng Part C Methods (2014) 0.77
Biomechanical forces in the skeleton and their relevance to bone metastasis: biology and engineering considerations. Adv Drug Deliv Rev (2014) 0.76
Modulation of the Mesenchymal Stem Cell Secretome Using Computer-Controlled Bioreactors: Impact on Neuronal Cell Proliferation, Survival and Differentiation. Sci Rep (2016) 0.75
Packed Bed Bioreactor for the Isolation and Expansion of Placental-Derived Mesenchymal Stromal Cells. PLoS One (2015) 0.75
Enhanced Viability of Endothelial Colony Forming Cells in Fibrin Microbeads for Sensor Vascularization. Sensors (Basel) (2015) 0.75
Expansion of mesenchymal stem cells under atmospheric carbon dioxide. Biotechnol Prog (2013) 0.75
Recent Advances in Tissue Engineering Strategies for the Treatment of Joint Damage. Curr Rheumatol Rep (2017) 0.75
Bioreactor culture duration of engineered constructs influences bone formation by mesenchymal stem cells. Biomaterials (2017) 0.75
Modeling Physiological Events in 2D vs. 3D Cell Culture. Physiology (Bethesda) (2017) 0.75
Process development of human multipotent stromal cell microcarrier culture using an automated high-throughput microbioreactor. Biotechnol Bioeng (2017) 0.75
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Signal transduction by the JNK group of MAP kinases. Cell (2000) 18.24
The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell (2002) 15.20
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science (2002) 14.50
Mitogen-activated protein kinase pathways. Curr Opin Cell Biol (1997) 9.10
Sox9 is required for cartilage formation. Nat Genet (1999) 7.89
Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol (2007) 6.63
The JNK signal transduction pathway. Curr Opin Cell Biol (2007) 5.86
SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol (1997) 5.72
Activation and signaling of the p38 MAP kinase pathway. Cell Res (2005) 5.48
Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus. Nat Rev Mol Cell Biol (2009) 5.41
Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell (2010) 4.98
Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev (2004) 4.78
Mechanisms and functions of p38 MAPK signalling. Biochem J (2010) 4.59
Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE (2007) 4.46
Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature (1998) 4.13
Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther (2007) 3.97
Integrins in mechanotransduction. J Biol Chem (2004) 3.57
The JNK signal transduction pathway. Curr Opin Genet Dev (2002) 3.35
SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem (2000) 3.20
Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem (2000) 2.98
Vascularized organoid engineered by modular assembly enables blood perfusion. Proc Natl Acad Sci U S A (2006) 2.82
Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem (2004) 2.71
Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell (2007) 2.70
Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun (2007) 2.67
Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochondrogenesis. J Cell Physiol (2001) 2.62
Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces. Proc Natl Acad Sci U S A (2003) 2.42
Engineering anatomically shaped human bone grafts. Proc Natl Acad Sci U S A (2009) 2.37
Cell mechanics and mechanotransduction: pathways, probes, and physiology. Am J Physiol Cell Physiol (2004) 2.32
Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng (2004) 2.26
Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J Biol Chem (2003) 2.25
Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. J Cell Physiol (2006) 2.24
Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. Proc Natl Acad Sci U S A (2002) 2.24
Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST. Blood (2010) 2.22
Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds. Biomaterials (2001) 1.94
Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J Biol Chem (2008) 1.84
Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res (2003) 1.82
The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches. Tissue Eng Part B Rev (2010) 1.81
Design of a flow perfusion bioreactor system for bone tissue-engineering applications. Tissue Eng (2003) 1.79
Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression. Bone (2007) 1.73
Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells. J Biol Chem (2001) 1.71
Effects of initial seeding density and fluid perfusion rate on formation of tissue-engineered bone. Tissue Eng Part A (2008) 1.70
Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription. J Cell Physiol (2005) 1.70
Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK. J Biol Chem (2007) 1.70
Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9. Bone (2005) 1.68
Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. J Biol Chem (2004) 1.68
Hypoxia in static and dynamic 3D culture systems for tissue engineering of bone. Tissue Eng Part A (2008) 1.65
Flow perfusion culture induces the osteoblastic differentiation of marrow stroma cell-scaffold constructs in the absence of dexamethasone. J Biomed Mater Res A (2005) 1.61
Ca(2+) regulates fluid shear-induced cytoskeletal reorganization and gene expression in osteoblasts. Am J Physiol Cell Physiol (2000) 1.59
Oxygen saturation in the bone marrow of healthy volunteers. Blood (2002) 1.58
Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation. J Biol Chem (2001) 1.57
Cyclic strain enhances matrix mineralization by adult human mesenchymal stem cells via the extracellular signal-regulated kinase (ERK1/2) signaling pathway. J Biomech (2003) 1.56
Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells. Exp Cell Res (2006) 1.55
RhoA/ROCK signaling regulates chondrogenesis in a context-dependent manner. J Biol Chem (2006) 1.55
Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone (2004) 1.54
Regulation of chondrogenesis and chondrocyte differentiation by stress. J Clin Invest (2008) 1.53
Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr Stem Cell Res Ther (2006) 1.51
Molecular regulation of mechanotransduction. Biochem Biophys Res Commun (2005) 1.51
Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng (2004) 1.51
The roles of hypoxia in the in vitro engineering of tissues. Tissue Eng (2007) 1.49
Hypoxia promotes chondrogenesis in rat mesenchymal stem cells: a role for AKT and hypoxia-inducible factor (HIF)-1alpha. J Cell Physiol (2008) 1.49
Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling. J Cell Biochem (2005) 1.48
Perfusion bioreactor system for human mesenchymal stem cell tissue engineering: dynamic cell seeding and construct development. Biotechnol Bioeng (2005) 1.48
Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells. J Biol Chem (2002) 1.48
Formation of three-dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor. J Biomed Mater Res (2002) 1.46
Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells. J Cell Biol (2009) 1.44
Induction of adipocyte-like phenotype in human mesenchymal stem cells by hypoxia. Stem Cells (2004) 1.43
Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification. J Biol Chem (2006) 1.41
Bone tissue engineering bioreactors: dynamic culture and the influence of shear stress. Bone (2010) 1.40
Long term culture of mesenchymal stem cells in hypoxia promotes a genetic program maintaining their undifferentiated and multipotent status. BMC Cell Biol (2011) 1.38
Mesenchymal stem cell ingrowth and differentiation on coralline hydroxyapatite scaffolds. Biomaterials (2006) 1.38
Fluid flow stimulates expression of osteopontin and bone sialoprotein by bone marrow stromal cells in a temporally dependent manner. Bone (2005) 1.37
Hypoxia and stem cell-based engineering of mesenchymal tissues. Biotechnol Prog (2009) 1.36
Bioreactor systems for bone tissue engineering. Tissue Eng Part B Rev (2011) 1.35
Mechanical signals as regulators of stem cell fate. Curr Top Dev Biol (2004) 1.35
Prolonged hypoxia concomitant with serum deprivation induces massive human mesenchymal stem cell death. Tissue Eng (2007) 1.33
Flow perfusion enhances the calcified matrix deposition of marrow stromal cells in biodegradable nonwoven fiber mesh scaffolds. Ann Biomed Eng (2005) 1.29
Hypoxia promotes proliferation and osteogenic differentiation potentials of human mesenchymal stem cells. J Orthop Res (2011) 1.27
Non-canonical Wnt signaling and N-cadherin related beta-catenin signaling play a role in mechanically induced osteogenic cell fate. PLoS One (2009) 1.26
Effects of shear stress on 3-D human mesenchymal stem cell construct development in a perfusion bioreactor system: Experiments and hydrodynamic modeling. Biotechnol Bioeng (2007) 1.26
Cartilage tissue engineering and bioreactor systems for the cultivation and stimulation of chondrocytes. Eur Biophys J (2007) 1.25
Bone tissue engineering in a rotating bioreactor using a microcarrier matrix system. J Biomed Mater Res (2001) 1.25
MAP kinase and calcium signaling mediate fluid flow-induced human mesenchymal stem cell proliferation. Am J Physiol Cell Physiol (2005) 1.23
Influence of shear stress in perfusion bioreactor cultures for the development of three-dimensional bone tissue constructs: a review. Tissue Eng Part B Rev (2010) 1.22
Stem cell cultivation in bioreactors. Biotechnol Adv (2011) 1.21
Effect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starch-based three-dimensional scaffolds. J Biomed Mater Res A (2003) 1.20
Bone tissue engineering: current strategies and techniques--part I: Scaffolds. Tissue Eng Part B Rev (2012) 1.20
Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells. J Cell Physiol (2004) 1.19
Human endothelial cells inhibit BMSC differentiation into mature osteoblasts in vitro by interfering with osterix expression. J Cell Biochem (2006) 1.15
Effect of fluid flow-induced shear stress on human mesenchymal stem cells: differential gene expression of IL1B and MAP3K8 in MAPK signaling. Gene Expr Patterns (2009) 1.15
Fluid flow increases type II collagen deposition and tensile mechanical properties in bioreactor-grown tissue-engineered cartilage. Tissue Eng (2006) 1.15
Shear- and compression-induced chondrocyte transcription requires MAPK activation in cartilage explants. J Biol Chem (2007) 1.15
In vitro expansion of adipose-derived adult stromal cells in hypoxia enhances early chondrogenesis. Tissue Eng (2007) 1.13
Bone regeneration on macroporous aqueous-derived silk 3-D scaffolds. Macromol Biosci (2007) 1.13
A perfusion bioreactor system capable of producing clinically relevant volumes of tissue-engineered bone: in vivo bone formation showing proof of concept. Biomaterials (2005) 1.13
Shear-induced cyclooxygenase-2 via a JNK2/c-Jun-dependent pathway regulates prostaglandin receptor expression in chondrocytic cells. J Biol Chem (2003) 1.11
Oxygen tension in zones of the epiphyseal plate, the metaphysis and diaphysis. An in vitro and in vivo study in rats and rabbits. J Bone Joint Surg Am (1971) 1.11
The influence of stereolithographic scaffold architecture and composition on osteogenic signal expression with rat bone marrow stromal cells. Biomaterials (2011) 1.07
Chondrogenic differentiation of mesenchymal stem cells and its clinical applications. Yonsei Med J (2004) 1.07
Effect of dynamic 3-D culture on proliferation, distribution, and osteogenic differentiation of human mesenchymal stem cells. J Biomed Mater Res A (2009) 1.06
Strategic directions in tissue engineering. Tissue Eng (2007) 2.70
Use of stereolithography to manufacture critical-sized 3D biodegradable scaffolds for bone ingrowth. J Biomed Mater Res B Appl Biomater (2003) 1.59
In vivo bone regeneration using tubular perfusion system bioreactor cultured nanofibrous scaffolds. Tissue Eng Part A (2013) 1.53
Effect of initial cell seeding density on early osteogenic signal expression of rat bone marrow stromal cells cultured on cross-linked poly(propylene fumarate) disks. Biomacromolecules (2009) 1.48
Bone tissue engineering bioreactors: dynamic culture and the influence of shear stress. Bone (2010) 1.40
Synthesis of poly(propylene fumarate). Nat Protoc (2009) 1.20
The influence of stereolithographic scaffold architecture and composition on osteogenic signal expression with rat bone marrow stromal cells. Biomaterials (2011) 1.07
Early osteogenic signal expression of rat bone marrow stromal cells is influenced by both hydroxyapatite nanoparticle content and initial cell seeding density in biodegradable nanocomposite scaffolds. Acta Biomater (2010) 1.05
Tubular perfusion system for the long-term dynamic culture of human mesenchymal stem cells. Tissue Eng Part C Methods (2010) 1.04
Stereolithographic bone scaffold design parameters: osteogenic differentiation and signal expression. Tissue Eng Part B Rev (2010) 1.03
Cyclic acetal hydrogel system for bone marrow stromal cell encapsulation and osteodifferentiation. J Biomed Mater Res A (2008) 1.03
Strategies and techniques to enhance the in situ endothelialization of small-diameter biodegradable polymeric vascular grafts. Tissue Eng Part B Rev (2013) 1.02
Tubular perfusion system culture of human mesenchymal stem cells on poly-L-lactic acid scaffolds produced using a supercritical carbon dioxide-assisted process. J Biomed Mater Res A (2012) 0.98
Human mesenchymal stem cell position within scaffolds influences cell fate during dynamic culture. Biotechnol Bioeng (2012) 0.98
Bone formation in transforming growth factor beta-1-coated porous poly(propylene fumarate) scaffolds. J Biomed Mater Res (2002) 0.98
Macroporous hydrogels upregulate osteogenic signal expression and promote bone regeneration. Biomacromolecules (2010) 0.98
Recent developments in cyclic acetal biomaterials for tissue engineering applications. Pharm Res (2008) 0.98
Formation of an aggregated alginate construct in a tubular perfusion system. Tissue Eng Part C Methods (2011) 0.98
Biomaterial scaffolds in pediatric tissue engineering. Pediatr Res (2008) 0.96
Evaluating 3D-printed biomaterials as scaffolds for vascularized bone tissue engineering. Adv Mater (2014) 0.95
Tissue engineering solutions for cleft palates. J Oral Maxillofac Surg (2007) 0.94
Continuous Digital Light Processing (cDLP): Highly Accurate Additive Manufacturing of Tissue Engineered Bone Scaffolds. Virtual Phys Prototyp (2012) 0.94
Evaluation of the in vitro cytotoxicity of cross-linked biomaterials. Biomacromolecules (2013) 0.94
Addition of hyaluronic acid to alginate embedded chondrocytes interferes with insulin-like growth factor-1 signaling in vitro and in vivo. Tissue Eng Part A (2009) 0.92
Multimodal imaging of sustained drug release from 3-D poly(propylene fumarate) (PPF) scaffolds. J Control Release (2011) 0.91
Optimal classes of chemotherapeutic agents sensitized by specific small-molecule inhibitors of akt in vitro and in vivo. Neoplasia (2005) 0.91
Nanoparticle technology in bone tissue engineering. J Drug Target (2007) 0.90
Macroporous hydrogel scaffolds and their characterization by optical coherence tomography. Tissue Eng Part C Methods (2010) 0.89
Chondrocyte signaling and artificial matrices for articular cartilage engineering. Adv Exp Med Biol (2006) 0.88
Effect of transforming growth factor beta 2 on marrow-infused foam poly(propylene fumarate) tissue-engineered constructs for the repair of critical-size cranial defects in rabbits. Tissue Eng (2005) 0.88
Synthesis and characterization of cyclic acetal based degradable hydrogels. Eur J Pharm Biopharm (2007) 0.88
Synthesis and properties of cyclic acetal biomaterials. J Biomed Mater Res A (2007) 0.88
Osteogenic differentiation of bone marrow stromal cells induced by coculture with chondrocytes encapsulated in three-dimensional matrices. Tissue Eng Part A (2009) 0.87
Validating continuous digital light processing (cDLP) additive manufacturing accuracy and tissue engineering utility of a dye-initiator package. Biofabrication (2014) 0.86
Synthesis of poly(L-lactide) and polyglycolide by ring-opening polymerization. Nat Protoc (2007) 0.86
Cellular responses to degradable cyclic acetal modified PEG hydrogels. J Biomed Mater Res A (2009) 0.85
Effect of construct properties on encapsulated chondrocyte expression of insulin-like growth factor-1. Biomaterials (2006) 0.84
Mesenchymal stem cells: roles and relationships in vascularization. Tissue Eng Part B Rev (2014) 0.84
Effects of exogenous IGF-1 delivery on the early expression of IGF-1 signaling molecules by alginate embedded chondrocytes. Tissue Eng Part A (2008) 0.83
Poly(propylene fumarate) and poly(DL-lactic-co-glycolic acid) as scaffold materials for solid and foam-coated composite tissue-engineered constructs for cranial reconstruction. Tissue Eng (2003) 0.83
Tissue response and orbital floor regeneration using cyclic acetal hydrogels. J Biomed Mater Res A (2009) 0.82
Phenotypic variations in chondrocyte subpopulations and their response to in vitro culture and external stimuli. Ann Biomed Eng (2010) 0.82
Porous EH and EH-PEG scaffolds as gene delivery vehicles to skeletal muscle. Pharm Res (2011) 0.81
Synergistic effect of sustained release of growth factors and dynamic culture on osteoblastic differentiation of mesenchymal stem cells. J Biomed Mater Res A (2014) 0.81
Gene expression of alginate-embedded chondrocyte subpopulations and their response to exogenous IGF-1 delivery. J Tissue Eng Regen Med (2011) 0.81
Matrix molecule influence on chondrocyte phenotype and proteoglycan 4 expression by alginate-embedded zonal chondrocytes and mesenchymal stem cells. J Orthop Res (2012) 0.81
Characterization of cyclic acetal hydroxyapatite nanocomposites for craniofacial tissue engineering. J Biomed Mater Res A (2010) 0.81
A novel internal fixator device for peripheral nerve regeneration. Tissue Eng Part C Methods (2012) 0.80
Self-folding thermo-magnetically responsive soft microgrippers. ACS Appl Mater Interfaces (2015) 0.80
Evaluating changes in structure and cytotoxicity during in vitro degradation of three-dimensional printed scaffolds. Tissue Eng Part A (2015) 0.79
Skeletal muscle tissue engineering approaches to abdominal wall hernia repair. Birth Defects Res C Embryo Today (2008) 0.79
EH Networks as a scaffold for skeletal muscle regeneration in abdominal wall hernia repair. J Surg Res (2007) 0.79
In vitro degradation and fracture toughness of multilayered porous poly(propylene fumarate)/beta-tricalcium phosphate scaffolds. J Biomed Mater Res (2002) 0.78
Cyclic acetal hydroxyapatite composites and endogenous osteogenic gene expression of rat marrow stromal cells. J Tissue Eng Regen Med (2010) 0.78
X-ray phase contrast imaging of calcified tissue and biomaterial structure in bioreactor engineered tissues. Biotechnol Bioeng (2014) 0.78
Chemo-enzymatic synthesis of degradable PTMC-b-PECA-b-PTMC triblock copolymers and their micelle formation for pH-dependent controlled release. Macromol Biosci (2009) 0.77
Fabrication and characterization of porous EH scaffolds and EH-PEG bilayers. J Biomed Mater Res A (2011) 0.77
Centrifugation assay for measuring adhesion of serially passaged bovine chondrocytes to polystyrene surfaces. Tissue Eng Part C Methods (2012) 0.77
Cyclic acetal hydroxyapatite nanocomposites for orbital bone regeneration. Tissue Eng Part A (2010) 0.77
Reinforced pericardium as a hybrid material for cardiovascular applications. Tissue Eng Part A (2014) 0.77
Photocrosslinked alginate with hyaluronic acid hydrogels as vehicles for mesenchymal stem cell encapsulation and chondrogenesis. J Biomed Mater Res A (2012) 0.77
Engineering superficial zone chondrocytes from mesenchymal stem cells. Tissue Eng Part C Methods (2014) 0.76
Tubular perfusion system for chondrocyte culture and superficial zone protein expression. J Biomed Mater Res A (2014) 0.76
Coculture strategies in bone tissue engineering: the impact of culture conditions on pluripotent stem cell populations. Tissue Eng Part B Rev (2012) 0.76
Development of a dynamic stem cell culture platform for mesenchymal stem cell adhesion and evaluation. Mol Pharm (2014) 0.75
A continued commitment to quality research in tissue engineering. Tissue Eng Part C Methods (2008) 0.75
3D Printed Pericardium Hydrogels To Promote Wound Healing in Vascular Applications. Biomacromolecules (2017) 0.75
Challenges associated with regeneration of orbital floor bone. Tissue Eng Part B Rev (2010) 0.75
3D printing PLGA: a quantitative examination of the effects of polymer composition and printing parameters on print resolution. Biofabrication (2017) 0.75
A continued commitment to quality research in tissue engineering. Tissue Eng Part B Rev (2008) 0.75
A continued commitment to quality research in tissue engineering. Tissue Eng Part A (2008) 0.75
Let's show how much we care. J Mass Dent Soc (2014) 0.75
How can the diagnosis be wrong if the patient's chart is illegible? J Mass Dent Soc (2006) 0.75